Claims that dozens of manufacturers already produce peptide API meeting the new HHS policy's quality standards are encouraging — if true. But as Scott Brunner points out, we have yet to see a single certificate of analysis demonstrating compliance. Labels like “API grade,” claims of cGMP manufacturing, and assurances from suppliers aren't enough. Compliance must be demonstrated through testing, not asserted on trust.